Novo investors call for dealmaking and new drugs
Ozempic maker is under pressure to diversify as it prepares to face shareholders on Monday
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.ft.com — the content belongs to Financial Times.
